Sensulin Company
Sensulin, LLC is developing a true once-a-day glucose-responsive insulin, that may mimic a healthy human pancreas. Sensulin may eliminate the need for basal & prandial insulin, offer a substantial improvement in the standard of care, and most importantly, give those with diabetes a chance at a normal life.
Technology:
Medical Devices
Industry:
Geroscience
Headquarters:
Oklahoma City, Oklahoma, United States
Zip:
1-10
Founded Date:
2011-08-09
Employees Number:
1-10
Funding Status:
Early Stage Venture
Acquisitions Number:
5
Investors Number:
3275000
Total Funding:
$1M to $10M
Estimated Revenue:
$1M to $10M
Last Funding Date:
Series A
Last Funding Type:
info@sensulin.com
Register and Claim Ownership